105 related articles for article (PubMed ID: 2944819)
1. [Clinical evaluation of the efficacy of a topical preparation containing pyridoxine and cystine in seborrheic dermatitis and in seborrheic condition of the face].
Melli MC; Giorgini S
G Ital Dermatol Venereol; 1986; 121(4):LI-LIII. PubMed ID: 2944819
[No Abstract] [Full Text] [Related]
2. Topical pimecrolimus in the treatment of seborrheic dermatitis.
Brownell I; Quan LT; Hsu S
Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of 17-desoxymethasone in the topical treatment of seborrheic eczema].
Martin López J
Actas Dermosifiliogr; 1977; 68(5-6):307-12. PubMed ID: 144424
[No Abstract] [Full Text] [Related]
4. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
[TBL] [Abstract][Full Text] [Related]
5. [Experiences with a new fat-soluble pyridoxine derivative in sebostatic and seborrheic diseases].
Chlebarov S; Borelli S
Praxis; 1966 Jan; 55(1):19-20. PubMed ID: 4223147
[No Abstract] [Full Text] [Related]
6. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
Ozden MG; Tekin NS; Ilter N; Ankarali H
Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trial with benzoyl peroxide shampoo in seborrhea oleosa].
Schmid U
Z Hautkr; 1976 Jul; 51(14):580-2. PubMed ID: 134521
[TBL] [Abstract][Full Text] [Related]
8. Steroid acne and rebound phenomenon.
Harlan SL
J Drugs Dermatol; 2008 Jun; 7(6):547-50. PubMed ID: 18561585
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
Ghittoni S; Orsucci O; Saviozzi A; Simonini P
Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
[No Abstract] [Full Text] [Related]
10. [Topical antiandrogen therapy in seborrheic blepharitis].
Prantera M; Pizzino A; Pizzino D; Varotti C
G Ital Dermatol Venereol; 1988 Nov; 123(11):581-2. PubMed ID: 2978266
[No Abstract] [Full Text] [Related]
11. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic activity of a preparation based on trichopeptide].
Romaguera Sagrera C
Med Cutan Ibero Lat Am; 1985; 13(6):557-62. PubMed ID: 2939308
[TBL] [Abstract][Full Text] [Related]
13. Seborrheic dermatitis of the scalp: etiology and treatment.
Gupta AK; Nicol KA
J Drugs Dermatol; 2004; 3(2):155-8. PubMed ID: 15098970
[TBL] [Abstract][Full Text] [Related]
14. [Clinical contribution to the treatment of dermatitis seborrheica of the face with ketoconazole cream].
Baran R
Ann Dermatol Venereol; 1987; 114(9):1135. PubMed ID: 2963581
[No Abstract] [Full Text] [Related]
15. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of seborrheic dermatitis using a low dose, oral homeopathic medication consisting of potassium bromide, sodium bromide, nickel sulfate, and sodium chloride in a double-blind, placebo-controlled study.
Smith SA; Baker AE; Williams JH
Altern Med Rev; 2002 Feb; 7(1):59-67. PubMed ID: 11896746
[TBL] [Abstract][Full Text] [Related]
17. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
18. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.
Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C
Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867
[TBL] [Abstract][Full Text] [Related]
20. Non-steroid skin cream in traumatic dermatoses: A clinical open evaluation.
Johnson A
Med J Aust; 1976 Jan; 1(5):111-3. PubMed ID: 131235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
